PGNY
Progyny, Inc.
Company overview
- Market capitalization
- $1.96B
- Employees
- 835
- Latest publication
- 2026-09-29
About Progyny, Inc.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 350,511,000USD | 328,504,000USD | 318,403,000USD | 313,346,000USD | 332,874,000USD | 324,038,000USD | 298,431,000USD | 286,625,000USD |
| Cost Of Revenue | 261,210,000USD | 245,433,000USD | 241,522,000USD | 240,511,000USD | 253,901,000USD | 248,243,000USD | 234,999,000USD | 227,381,000USD |
| Gross Profit | 89,301,000USD | 83,071,000USD | 76,881,000USD | 72,835,000USD | 78,973,000USD | 75,795,000USD | 63,432,000USD | 59,244,000USD |
| Selling And Marketing Expenses | 18,074,000USD | 16,884,000USD | — | 17,935,000USD | 18,405,000USD | 17,786,000USD | 15,616,000USD | 16,457,000USD |
| General And Administrative Expenses | 31,224,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 49,298,000USD | 47,692,000USD | 61,659,000USD | 51,308,000USD | 54,615,000USD | 51,625,000USD | 47,645,000USD | 46,786,000USD |
| Operating Income | 40,003,000USD | 35,379,000USD | 15,222,000USD | 21,527,000USD | 24,358,000USD | 24,170,000USD | 15,787,000USD | 12,458,000USD |
| Total Other Income Expense Net | 1,134,000USD | 1,504,000USD | 2,632,000USD | 2,437,000USD | 2,719,000USD | 2,367,000USD | 1,871,000USD | 5,504,000USD |
| Income Before Tax | 41,137,000USD | 36,883,000USD | 17,854,000USD | 23,964,000USD | 27,077,000USD | 26,537,000USD | 17,658,000USD | 17,962,000USD |
| Income Tax Expense | 13,085,000USD | 12,651,000USD | 5,369,000USD | 10,100,000USD | 9,965,000USD | 11,478,000USD | 7,126,000USD | 7,541,000USD |
| Net Income | 28,052,000USD | 24,232,000USD | 12,485,000USD | 13,864,000USD | 17,112,000USD | 15,059,000USD | 10,532,000USD | 10,421,000USD |
| Selling General Administrative | — | 30,808,000USD | 44,772,000USD | 32,273,000USD | 36,210,000USD | 33,839,000USD | 32,029,000USD | 30,329,000USD |
| Interest Income | — | 1,504,000USD | 2,632,000USD | 2,437,000USD | 2,719,000USD | 2,367,000USD | 1,871,000USD | 5,504,000USD |
| Net Interest Income | — | 1,504,000USD | 2,632,000USD | 2,437,000USD | 2,719,000USD | 2,367,000USD | 1,871,000USD | 5,504,000USD |
| Tax Provision | — | 12,651,000USD | 5,369,000USD | 10,100,000USD | 9,965,000USD | 11,478,000USD | 7,126,000USD | 7,541,000USD |
| Net Income From Continuing Ops | — | 24,232,000USD | 12,485,000USD | 13,864,000USD | 17,112,000USD | 15,059,000USD | 10,532,000USD | 10,421,000USD |
| Ebit | — | 36,883,000USD | 17,854,000USD | 23,964,000USD | 27,077,000USD | 26,537,000USD | 17,658,000USD | 17,962,000USD |
| Ebitda | — | 38,366,000USD | 19,221,000USD | 25,232,000USD | 28,282,000USD | 27,645,000USD | 18,526,000USD | 18,799,000USD |
| Depreciation And Amortization | — | 1,483,000USD | 1,367,000USD | 1,268,000USD | 1,205,000USD | 1,108,000USD | 868,000USD | 837,000USD |
| Reconciled Depreciation | — | 1,483,000USD | 1,367,000USD | 1,268,000USD | 1,205,000USD | 1,108,000USD | 868,000USD | 837,000USD |
| Unclassified Operating Expenses | — | — | 16,887,000USD | 1,100,000USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 1,288,661,000USD | 1,167,221,000USD | 1,088,598,000USD | 786,913,000USD | 500,621,000USD | 344,858,000USD | 229,683,000USD |
| Cost Of Revenue | 984,177,000USD | 913,858,000USD | 849,799,000USD | 619,588,000USD | 388,486,000USD | 274,799,000USD | 184,178,000USD |
| Gross Profit | 304,484,000USD | 253,363,000USD | 238,799,000USD | 167,325,000USD | 112,135,000USD | 70,059,000USD | 45,505,000USD |
| Selling General Administrative | 147,094,000USD | 121,960,000USD | 117,127,000USD | 98,327,000USD | 59,616,000USD | 46,705,000USD | 23,927,000USD |
| Selling And Marketing Expenses | 72,113,000USD | 63,948,000USD | 59,488,000USD | 45,657,000USD | 20,179,000USD | 15,006,000USD | 11,901,000USD |
| Total Operating Expenses | 219,207,000USD | 185,908,000USD | 176,615,000USD | 143,984,000USD | 79,795,000USD | 61,711,000USD | 35,828,000USD |
| Operating Income | 85,277,000USD | 67,455,000USD | 62,184,000USD | 23,341,000USD | 32,340,000USD | 8,348,000USD | 9,677,000USD |
| Interest Income | 10,155,000USD | 15,747,000USD | 8,507,000USD | 814,000USD | — | — | 58,000USD |
| Net Interest Income | 10,155,000USD | 15,747,000USD | 3,122,000USD | 814,000USD | 461,000USD | 121,000USD | -58,000USD |
| Income Before Tax | 95,432,000USD | 83,202,000USD | 70,691,000USD | 24,441,000USD | 32,435,000USD | 8,679,000USD | -8,557,000USD |
| Income Tax Expense | 36,912,000USD | 28,866,000USD | 8,654,000USD | -5,917,000USD | -33,334,000USD | -37,780,000USD | 12,000USD |
| Tax Provision | 36,912,000USD | 28,866,000USD | 6,595,000USD | -5,917,000USD | -33,334,000USD | -37,780,000USD | 12,000USD |
| Net Income | 58,520,000USD | 54,336,000USD | 62,037,000USD | 30,358,000USD | 65,769,000USD | 46,459,000USD | -8,569,000USD |
| Net Income From Continuing Ops | 58,520,000USD | 54,336,000USD | 51,975,000USD | 30,358,000USD | 65,769,000USD | 46,459,000USD | -8,569,000USD |
| Ebit | 95,432,000USD | 83,202,000USD | 70,691,000USD | 24,441,000USD | 32,435,000USD | 8,348,000USD | 9,677,000USD |
| Ebitda | 100,380,000USD | 86,377,000USD | 72,972,000USD | 26,042,000USD | 33,736,000USD | 10,254,000USD | 11,810,000USD |
| Depreciation And Amortization | 4,948,000USD | 3,175,000USD | 2,281,000USD | 1,601,000USD | 1,301,000USD | 1,906,000USD | 2,133,000USD |
| Reconciled Depreciation | 4,948,000USD | 3,175,000USD | 2,093,000USD | 1,601,000USD | 1,301,000USD | 1,906,000USD | 2,133,000USD |
| Total Other Income Expense Net | 10,155,000USD | 15,747,000USD | 8,507,000USD | 1,100,000USD | 95,000USD | 331,000USD | -18,234,000USD |
| Interest Expense | — | — | — | 814,000USD | 461,000USD | 121,000USD | 58,000USD |
| Non Operating Income Net Other | — | — | — | 286,000USD | -366,000USD | 210,000USD | — |
| Net Income Applicable To Common Shares | — | — | — | 30,358,000USD | 65,769,000USD | 46,459,000USD | -8,569,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 715,836,000USD | 698,337,000USD | 742,435,000USD | 795,227,000USD | 760,950,000USD | 730,285,000USD | 607,102,000USD | 659,972,000USD |
| Cash And Equivalents | 152,632,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 513,018,000USD | 501,551,000USD | 551,775,000USD | 622,013,000USD | 594,402,000USD | 567,692,000USD | 472,721,000USD | 546,302,000USD |
| Other Current Assets | 18,617,000USD | 11,788,000USD | 21,392,000USD | 24,304,000USD | 17,457,000USD | 11,826,000USD | 9,443,000USD | 29,858,000USD |
| Other Non Current Assets | 18,571,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 262,579,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 240,084,000USD | 235,742,000USD | 202,391,000USD | 210,493,000USD | 220,423,000USD | 237,128,000USD | 168,627,000USD | 208,471,000USD |
| Total Stockholder Equity | 453,257,000USD | 439,344,000USD | 516,044,000USD | 560,004,000USD | 515,022,000USD | 467,159,000USD | 422,062,000USD | 434,876,000USD |
| Total Equity Including Noncontrolling Interest | 453,257,000USD | — | — | — | — | — | — | — |
| Net Receivables | 257,476,000USD | 263,613,000USD | 220,287,000USD | 252,502,000USD | 271,853,000USD | 299,743,000USD | 235,324,000USD | 280,724,000USD |
| Property Plant Equipment Net | 65,569,000USD | 59,984,000USD | 54,917,000USD | 50,422,000USD | 46,366,000USD | 42,689,000USD | 29,634,000USD | 29,367,000USD |
| Goodwill | 19,853,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 152,050,000USD | 157,826,000USD | 124,071,000USD | 123,089,000USD | 140,517,000USD | 145,713,000USD | 95,097,000USD | 130,463,000USD |
| Common Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD |
| Retained Earnings | 255,111,000USD | 227,059,000USD | 202,827,000USD | 190,342,000USD | 176,478,000USD | 159,366,000USD | 144,307,000USD | 133,775,000USD |
| Accumulated Other Comprehensive Income | 245,000USD | 277,000USD | 498,000USD | 419,000USD | 218,000USD | 110,000USD | 39,000USD | 330,000USD |
| Intangible Assets | — | 5,970,999USD | 6,216,000USD | 6,428,000USD | 6,644,000USD | 6,753,000USD | 1,303,000USD | 1,448,000USD |
| Total Liab | — | 258,993,000USD | 226,391,000USD | 235,223,000USD | 245,928,000USD | 263,126,000USD | 185,040,000USD | 225,096,000USD |
| Other Current Liab | — | 73,887,000USD | 74,594,000USD | 83,984,000USD | 79,906,000USD | 91,415,000USD | 70,671,000USD | 78,008,000USD |
| Capital Stock | — | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD |
| Good Will | — | 19,879,000USD | 19,978,000USD | 19,964,000USD | 19,963,000USD | 19,651,000USD | 15,534,000USD | 15,796,000USD |
| Cash | — | 132,645,999USD | 112,238,000USD | 133,982,000USD | 132,506,000USD | 109,239,000USD | 162,314,000USD | 91,480,000USD |
| Cash And Short Term Investments | — | 226,150,000USD | 310,096,000USD | 345,207,000USD | 305,092,000USD | 256,123,000USD | 227,954,000USD | 235,720,000USD |
| Net Debt | — | -105,365,999USD | -84,512,000USD | -105,832,000USD | -107,001,000USD | -83,241,000USD | -143,042,000USD | -74,855,000USD |
| Short Term Debt | — | 4,029,000USD | 3,726,000USD | 3,420,000USD | 3,124,000USD | 2,898,000USD | 2,859,000USD | 2,872,000USD |
| Short Long Term Debt Total | — | 27,280,000USD | 27,726,000USD | 28,150,000USD | 25,505,000USD | 25,998,000USD | 19,272,000USD | 16,625,000USD |
| Short Term Investments | — | 93,504,000USD | 197,858,000USD | 211,225,000USD | 172,586,000USD | 146,884,000USD | 65,640,000USD | 144,240,000USD |
| Property Plant Equipment Gross | — | 59,984,000USD | 67,261,000USD | 50,422,000USD | 46,366,000USD | 42,689,000USD | 38,002,000USD | 29,367,000USD |
| Common Stock Shares Outstanding | — | 84,755,262shares | 89,464,571shares | 90,226,278shares | 89,638,677shares | 89,307,934shares | 95,448,357shares | 93,821,812shares |
| Non Current Assets Total | — | 196,786,000USD | 190,660,000USD | 173,213,999USD | 166,548,000USD | 162,593,000USD | 134,381,000USD | 113,670,000USD |
| Non Current Liabilities Total | — | 23,251,000USD | 24,000,000USD | 24,730,000USD | 25,505,000USD | 25,998,000USD | 16,413,000USD | 16,625,000USD |
| Non Currrent Assets Other | — | 16,947,000USD | 16,536,000USD | 11,526,999USD | 8,633,000USD | 8,552,000USD | 2,977,000USD | 3,302,000USD |
| Net Working Capital | — | 265,809,000USD | 349,384,000USD | 411,520,000USD | 373,979,000USD | 330,564,000USD | 304,094,000USD | 337,831,000USD |
| Unclassified Non Current Assets | — | 94,005,001USD | 93,013,000USD | 84,873,000USD | 84,942,000USD | 84,948,000USD | 84,933,000USD | 63,757,000USD |
| Unclassified Non Current Liabilities | — | 23,251,000USD | 24,000,000USD | 24,730,000USD | 25,505,000USD | 25,998,000USD | 16,413,000USD | 16,625,000USD |
| Unclassified Equity | — | 211,990,000USD | 312,701,000USD | 369,225,000USD | 338,308,000USD | 307,665,000USD | 277,698,000USD | 300,753,000USD |
| Unclassified Current Liabilities | — | — | — | — | -3,124,000USD | -2,898,000USD | — | -2,872,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 742,435,000USD | 607,102,000USD | 756,620,000USD | 542,986,000USD | 358,065,000USD | 253,927,000USD | 150,434,000USD | 41,324,000USD |
| Intangible Assets | 6,216,000USD | 1,303,000USD | — | 99,000USD | 599,000USD | 1,213,000USD | 2,375,000USD | 3,859,000USD |
| Other Current Assets | 21,392,000USD | 9,443,000USD | 27,451,000USD | 4,489,000USD | 4,564,000USD | 5,259,000USD | 5,003,000USD | 1,085,000USD |
| Total Liab | 226,391,000USD | 185,040,000USD | 203,191,000USD | 166,018,000USD | 106,243,000USD | 86,980,000USD | 36,163,000USD | 30,202,000USD |
| Total Stockholder Equity | 516,044,000USD | 422,062,000USD | 553,429,000USD | 376,968,000USD | 251,822,000USD | 166,947,000USD | 114,271,000USD | 11,122,000USD |
| Other Current Liab | 74,594,000USD | 70,671,000USD | 58,375,000USD | 49,018,000USD | 36,194,000USD | 33,041,000USD | 16,775,000USD | 14,371,000USD |
| Common Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 1,000USD |
| Capital Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 106,238,000USD |
| Retained Earnings | 202,827,000USD | 144,307,000USD | 89,971,000USD | 27,934,000USD | -2,424,000USD | -68,193,000USD | -113,483,000USD | -104,854,000USD |
| Good Will | 19,978,000USD | 15,534,000USD | 11,880,000USD | 11,880,000USD | 11,880,000USD | 11,880,000USD | 11,880,000USD | 11,880,000USD |
| Cash | 112,238,000USD | 162,314,000USD | 97,296,000USD | 120,078,000USD | 91,413,000USD | 70,305,000USD | 80,382,000USD | 127,000USD |
| Cash And Short Term Investments | 310,096,000USD | 227,954,000USD | 371,087,000USD | 189,300,000USD | 119,418,000USD | 109,299,000USD | 80,382,000USD | 127,000USD |
| Total Current Assets | 551,775,000USD | 472,721,000USD | 640,407,000USD | 433,856,000USD | 258,539,000USD | 190,222,000USD | 132,444,000USD | 24,537,000USD |
| Total Current Liabilities | 202,391,000USD | 168,627,000USD | 185,950,000USD | 159,536,000USD | 98,824,000USD | 77,786,000USD | 36,163,000USD | 30,202,000USD |
| Net Debt | -84,512,000USD | -143,042,000USD | -77,906,000USD | -112,365,000USD | -82,763,000USD | -60,756,000USD | -80,382,000USD | 126,000USD |
| Short Term Debt | 3,726,000USD | 2,859,000USD | 2,149,000USD | 1,231,000USD | 1,231,000USD | 1,231,000USD | — | 253,000USD |
| Short Long Term Debt Total | 27,726,000USD | 19,272,000USD | 19,390,000USD | 7,713,000USD | 8,650,000USD | 9,549,000USD | — | 253,000USD |
| Short Term Investments | 197,858,000USD | 65,640,000USD | 273,791,000USD | 69,222,000USD | 28,005,000USD | 38,994,000USD | — | — |
| Net Receivables | 220,287,000USD | 235,324,000USD | 241,869,000USD | 240,067,000USD | 134,557,000USD | 75,664,000USD | 47,059,000USD | 23,325,000USD |
| Accounts Payable | 124,071,000USD | 95,097,000USD | 125,426,000USD | 109,287,000USD | 61,399,000USD | 43,514,000USD | 19,388,000USD | 15,578,000USD |
| Property Plant Equipment Net | 54,917,000USD | 29,634,000USD | 27,818,000USD | 15,274,000USD | 12,832,000USD | 12,068,000USD | 3,083,000USD | 776,000USD |
| Property Plant Equipment Gross | 67,261,000USD | 38,002,000USD | 33,119,000USD | 15,274,000USD | 12,832,000USD | 12,068,000USD | 3,083,000USD | 776,000USD |
| Accumulated Other Comprehensive Income | 498,000USD | 39,000USD | 2,819,000USD | 501,000USD | -93,000USD | 1,000USD | -150,434,000USD | -483,000USD |
| Common Stock Shares Outstanding | 89,464,571shares | 95,448,357shares | 100,672,399shares | 99,957,173shares | 100,358,047shares | 99,055,526shares | 83,572,222shares | 81,561,714shares |
| Non Current Assets Total | 190,660,000USD | 134,381,000USD | 116,213,000USD | 109,130,000USD | 99,526,000USD | 63,705,000USD | 17,990,000USD | 16,787,000USD |
| Non Current Liabilities Total | 24,000,000USD | 16,413,000USD | 17,241,000USD | 6,482,000USD | 7,419,000USD | 9,194,000USD | 19,388,000USD | 106,237,000USD |
| Non Currrent Assets Other | 16,536,000USD | 2,977,000USD | 3,395,000USD | 3,988,000USD | 2,941,000USD | 573,000USD | 652,000USD | 272,000USD |
| Net Working Capital | 349,384,000USD | 304,094,000USD | 454,457,000USD | 274,320,000USD | 159,715,000USD | 112,436,000USD | 96,281,000USD | -5,665,000USD |
| Unclassified Non Current Assets | 93,013,000USD | 84,933,000USD | 73,120,000USD | -3,988,000USD | -2,941,000USD | 29,753,000USD | — | — |
| Unclassified Non Current Liabilities | 24,000,000USD | 16,413,000USD | 17,241,000USD | — | — | — | 19,388,000USD | 106,237,000USD |
| Unclassified Equity | 312,701,000USD | 277,698,000USD | 460,621,000USD | 348,515,000USD | 254,321,000USD | 235,121,000USD | 379,181,000USD | 11,104,000USD |
| Current Deferred Revenue | — | — | 57,192,000USD | — | 34,022,000USD | -1,231,000USD | — | 9,386,000USD |
| Inventory | — | — | 1USD | — | 1USD | — | — | — |
| Unclassified Current Liabilities | — | — | -57,192,000USD | — | -34,022,000USD | — | — | -9,639,000USD |
| Other Assets | — | — | — | 81,877,000USD | 74,215,000USD | 8,218,000USD | 652,000USD | 272,000USD |
| Non Current Liabilities Other | — | — | — | 6,482,000USD | 7,419,000USD | 9,194,000USD | — | — |
| Net Tangible Assets | — | — | — | 364,989,000USD | 239,343,000USD | 153,854,000USD | 100,016,000USD | -110,854,000USD |
| Other Liab | — | — | — | — | — | 876,000USD | — | — |
| Treasury Stock | — | — | — | — | — | — | -1,009,000USD | -884,000USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 253,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 24,232,000USD | 12,485,000USD | 13,864,000USD | 17,112,000USD | 15,059,000USD | 10,532,000USD | 10,421,000USD | 16,485,000USD |
| Depreciation | 1,483,000USD | 1,367,000USD | 1,268,000USD | 1,205,000USD | 1,108,000USD | 868,000USD | 837,000USD | 754,000USD |
| Stock Based Compensation | 19,721,000USD | 34,799,000USD | 32,173,000USD | 32,383,000USD | 32,512,000USD | 30,859,000USD | 33,183,000USD | 33,036,000USD |
| Other Non Cash Items | 5,917,000USD | 4,902,000USD | 4,148,000USD | 4,279,000USD | 6,844,000USD | 6,720,000USD | 6,437,000USD | 1,316,000USD |
| Change To Account Receivables | -47,773,000USD | 27,038,000USD | 15,011,000USD | 22,566,000USD | -69,732,000USD | 41,705,000USD | 9,917,000USD | -1,378,000USD |
| Change In Working Capital | -5,414,000USD | 8,796,000USD | -790,000USD | 519,000USD | -5,726,000USD | 23,992,000USD | -11,192,000USD | 2,458,000USD |
| Total Cash From Operating Activities | 45,949,000USD | 54,203,000USD | 50,671,000USD | 55,510,000USD | 49,808,000USD | 52,164,000USD | 44,515,000USD | 56,694,000USD |
| Capital Expenditures | -6,347,000USD | -5,614,000USD | -4,684,000USD | -5,269,000USD | -2,843,000USD | -1,895,000USD | -1,794,000USD | -866,000USD |
| Free Cash Flow | 39,602,000USD | 48,589,000USD | 45,987,000USD | 50,241,000USD | 46,965,000USD | 50,269,000USD | 42,721,000USD | 55,828,000USD |
| Investments | 102,941,000USD | 13,870,000USD | -42,744,000USD | -29,915,000USD | -94,610,000USD | 74,990,000USD | 15,362,000USD | 86,096,000USD |
| Total Cashflows From Investing Activities | 96,594,000USD | 8,256,000USD | -42,744,000USD | -29,915,000USD | -94,610,000USD | 74,990,000USD | 15,362,000USD | 86,096,000USD |
| Total Cash From Financing Activities | -123,114,000USD | -88,259,000USD | -5,486,000USD | -2,329,000USD | -3,288,000USD | -56,327,000USD | -63,353,000USD | -162,789,000USD |
| Sale Purchase Of Stock | -118,607,000USD | -81,657,000USD | 3,583,000USD | 0USD | -3,583,000USD | -55,102,000USD | -61,453,000USD | -159,959,000USD |
| Change In Cash | 20,407,999USD | -21,744,000USD | 1,476,000USD | 23,303,000USD | -53,075,000USD | 70,834,000USD | -3,480,000USD | -19,999,000USD |
| Begin Period Cash Flow | 112,238,000USD | 133,982,000USD | 132,506,000USD | 114,239,000USD | 162,314,000USD | 91,480,000USD | 94,960,000USD | 114,959,000USD |
| End Period Cash Flow | 132,645,999USD | 112,238,000USD | 133,982,000USD | 137,542,000USD | 109,239,000USD | 162,314,000USD | 91,480,000USD | 94,960,000USD |
| Other Cashflows From Financing Activities | -4,844,000USD | -7,028,000USD | -5,712,000USD | -2,612,000USD | -3,583,000USD | -1,612,000USD | -2,217,000USD | -2,830,000USD |
| Unclassified Operating Cash Flow | — | -8,146,000USD | — | — | — | -20,807,000USD | 4,829,000USD | 2,645,000USD |
| Unclassified Investing Cash Flow | — | — | 4,684,000USD | 5,269,000USD | 2,843,000USD | 1,895,000USD | 1,794,000USD | — |
| Unclassified Financing Cash Flow | — | — | -3,357,000USD | — | 3,878,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 58,520,000USD | 54,336,000USD | 62,037,000USD | 30,358,000USD | 65,769,000USD | 46,459,000USD | -8,569,000USD | 661,000USD |
| Depreciation | 4,948,000USD | 3,175,000USD | 2,281,000USD | 1,601,000USD | 1,301,000USD | 1,906,000USD | 2,133,000USD | 1,883,000USD |
| Stock Based Compensation | 131,867,000USD | 128,130,000USD | 122,611,000USD | 100,748,000USD | 33,706,000USD | 12,821,000USD | 5,061,000USD | 2,997,000USD |
| Other Non Cash Items | 20,173,000USD | 15,695,000USD | 15,564,000USD | 13,794,000USD | 9,821,000USD | 5,637,000USD | 19,783,000USD | -1,846,000USD |
| Change To Account Receivables | -5,117,000USD | -9,874,000USD | -21,738,000USD | -119,304,000USD | -68,676,000USD | -35,336,000USD | -25,342,000USD | -12,776,000USD |
| Change In Working Capital | 2,799,000USD | -11,775,000USD | -17,424,000USD | -59,491,000USD | -51,257,000USD | 7,351,000USD | -19,954,000USD | 354,000USD |
| Total Cash From Operating Activities | 210,192,000USD | 179,105,000USD | 188,814,000USD | 80,395,000USD | 26,037,000USD | 36,203,000USD | -1,534,000USD | 2,272,000USD |
| Capital Expenditures | -18,410,000USD | -5,405,000USD | -3,644,000USD | -3,241,000USD | -2,129,000USD | -1,037,000USD | -2,956,000USD | -579,000USD |
| Free Cash Flow | 191,782,000USD | 173,700,000USD | 185,170,000USD | 77,154,000USD | 23,908,000USD | 35,166,000USD | -4,490,000USD | 1,693,000USD |
| Investments | -131,263,000USD | 195,792,000USD | -108,284,000USD | -43,866,000USD | 10,895,000USD | -38,994,000USD | -2,756,000USD | 1,902,000USD |
| Total Cashflows From Investing Activities | -159,013,000USD | 195,792,000USD | -200,525,000USD | -43,866,000USD | 8,766,000USD | -40,031,000USD | -2,756,000USD | 1,902,000USD |
| Total Cash From Financing Activities | -99,362,000USD | -309,880,000USD | -11,072,000USD | -7,864,000USD | -13,695,000USD | -6,249,000USD | 84,545,000USD | -8,738,000USD |
| Sale Purchase Of Stock | -81,657,000USD | -300,278,000USD | -17,200,000USD | -12,089,000USD | -17,966,000USD | -8,930,000USD | -185,000USD | -3,705,000USD |
| Change In Cash | -48,121,000USD | 65,018,000USD | -22,782,000USD | 28,665,000USD | 21,108,000USD | -10,077,000USD | 80,255,000USD | -4,564,000USD |
| Begin Period Cash Flow | 162,314,000USD | 97,296,000USD | 120,078,000USD | 91,413,000USD | 70,305,000USD | 80,382,000USD | 127,000USD | 4,691,000USD |
| End Period Cash Flow | 114,193,000USD | 162,314,000USD | 97,296,000USD | 120,078,000USD | 91,413,000USD | 70,305,000USD | 80,382,000USD | 127,000USD |
| Other Cashflows From Financing Activities | -18,935,000USD | -12,001,000USD | -17,200,000USD | -12,089,000USD | -17,966,000USD | -8,930,000USD | 3,763,000USD | -2,435,000USD |
| Unclassified Operating Cash Flow | -8,115,000USD | -10,456,000USD | 3,745,000USD | -6,615,000USD | -33,303,000USD | -37,971,000USD | — | -1,777,000USD |
| Unclassified Investing Cash Flow | -9,340,000USD | 5,405,000USD | -88,597,000USD | 43,866,000USD | -10,895,000USD | 38,994,000USD | 2,756,000USD | -1,902,000USD |
| Unclassified Financing Cash Flow | 1,230,000USD | — | 23,328,000USD | 16,314,000USD | 22,237,000USD | 11,611,000USD | 81,220,000USD | 2,500,000USD |
| Change To Inventory | — | — | -12,569,000USD | — | 2,859,000USD | 17,074,000USD | 2,267,000USD | 2,582,000USD |
| Change To Liabilities | — | — | — | 60,836,000USD | 17,840,000USD | 42,408,000USD | 3,501,000USD | 10,448,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 28,665,000USD | 21,108,000USD | -10,077,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | -40,625,000USD | 10,895,000USD | -38,994,000USD | 200,000USD | 2,481,000USD |
| Net Borrowings | — | — | — | — | 0USD | — | -253,000USD | -5,098,000USD |
| Issuance Of Capital Stock | — | — | — | — | 0USD | 0USD | 78,385,000USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Fertility Benefit Services | 230,209,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Pharmacy Benefit Services | 120,302,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Fertility Benefit Services | 209,434,000 | USD | 0001551306-26-000068 |
| Q1 2026Quarterly · 2026-03-31 | Product | Pharmacy Benefit Services | 119,070,000 | USD | 0001551306-26-000068 |
| Q4 2025Quarterly · 2025-12-31 | Product | Fertility Benefit Services | 208,635,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Pharmacy Benefit Services | 109,768,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Fertility Benefit Services | 830,929,000 | USD | 0001551306-26-000020 |
| FY 2025Yearly · 2025-12-31 | Product | Pharmacy Benefit Services | 457,732,000 | USD | 0001551306-26-000020 |
| Q3 2025Quarterly · 2025-09-30 | Product | Fertility Benefit Services | 201,946,000 | USD | 0001551306-25-000190 |
| Q3 2025Quarterly · 2025-09-30 | Product | Pharmacy Benefit Services | 111,400,000 | USD | 0001551306-25-000190 |
| Q2 2025Quarterly · 2025-06-30 | Product | Fertility Benefit Services | 213,943,000 | USD | 0001551306-25-000165 |
| Q2 2025Quarterly · 2025-06-30 | Product | Pharmacy Benefit Services | 118,931,000 | USD | 0001551306-25-000165 |
| Q1 2025Quarterly · 2025-03-31 | Product | Fertility Benefit Services | 206,405,000 | USD | 0001551306-26-000068 |
| Q1 2025Quarterly · 2025-03-31 | Product | Pharmacy Benefit Services | 117,633,000 | USD | 0001551306-26-000068 |
| Q4 2024Quarterly · 2024-12-31 | Product | Fertility Benefit Services | 187,461,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Pharmacy Benefit Services | 110,970,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Fertility Benefit Services | 729,551,000 | USD | 0001551306-26-000020 |
| FY 2024Yearly · 2024-12-31 | Product | Pharmacy Benefit Services | 437,670,000 | USD | 0001551306-26-000020 |
| Q3 2024Quarterly · 2024-09-30 | Product | Fertility Benefit Services | 178,758,000 | USD | 0001551306-25-000190 |
| Q3 2024Quarterly · 2024-09-30 | Product | Pharmacy Benefit Services | 107,867,000 | USD | 0001551306-25-000190 |
| FY 2023Yearly · 2023-12-31 | Product | Fertility Benefit Services | 676,295,000 | USD | 0001551306-26-000020 |
| FY 2023Yearly · 2023-12-31 | Product | Pharmacy Benefit Services | 412,303,000 | USD | 0001551306-26-000020 |
| FY 2022Yearly · 2022-12-31 | Product | Fertility Benefit Services | 510,145,000 | USD | 0001551306-25-000040 |
| FY 2022Yearly · 2022-12-31 | Product | Pharmacy Benefit Services | 276,768,000 | USD | 0001551306-25-000040 |
| FY 2021Yearly · 2021-12-31 | Product | Fertility Benefit Services | 355,616,000 | USD | 0001551306-24-000031 |
| FY 2021Yearly · 2021-12-31 | Product | Pharmacy Benefit Services | 145,005,000 | USD | 0001551306-24-000031 |
| FY 2020Yearly · 2020-12-31 | Product | Fertility Benefit Services | 253,556,000 | USD | 0001551306-23-000015 |
| FY 2020Yearly · 2020-12-31 | Product | Pharmacy Benefit Services | 91,302,000 | USD | 0001551306-23-000015 |
| FY 2019Yearly · 2019-12-31 | Product | Fertility Benefit Services | 189,618,000 | USD | 0001558370-22-002466 |
| FY 2019Yearly · 2019-12-31 | Product | Pharmacy Benefit Services | 40,065,000 | USD | 0001558370-22-002466 |
| FY 2018Yearly · 2018-12-31 | Product | Fertility Benefit Services | 99,786,000 | USD | 0001558370-21-002082 |
| FY 2018Yearly · 2018-12-31 | Product | Pharmacy Benefit Services | 5,614,000 | USD | 0001558370-21-002082 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.